Borderline personality and mood disorders: Risk factors, precursors, and early signs in childhood and youth

Borderline Personality and Mood Disorders: Comorbidity and Controversy

Volumn , Issue , 2015, Pages 155-174

  Chanen, Andrew M ^a,b   Thompson, Katherine ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84944059631     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-1314-5_9     Document Type: Chapter

References (109)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602.
2. de Girolamo G, Dagani J, Purcell R, Cocchi A, McGorry PD. Age of onset of mental disorders and use of mental health services: needs, opportunities and obstacles. Epidemiol Psychiatr Serv. 2012;21:47–57.
3. Chanen AM, McCutcheon LK. Prevention and early intervention for borderline personality disorder: current status and recent evidence. Br J Psychiatry. 2013;202(S54):s24–9.
4. Cohen P, Crawford TN, Johnson JG, Kasen S. The children in the community study of developmental course of personality disorder. J Pers Disord. 2005;19(5):466–86.
5. Paris J. Personality disorders begin in adolescence. J Can Acad Child Adolesc Psychiatry. 2013;22(3):195–6.
6. McGorry PD. Early clinical phenotypes and risk for serious mental disorders in young people: need for care precedes traditional diagnoses in mood and psychotic disorders. Can J Psychiatry. 2013;58(1):19–21.
7. Paris J. Personality disorders and mood disorders: phenomenological resemblances vs. pathogenetic pathways. J Pers Disord. 2010;24(1):3–13.
8. Perugi G, Angst J, Azorin JM, Bowden C, Vieta E, Young AH. The bipolar-borderline personality disorders connection in major depressive patients. Acta Psychiatr Scand. 2013; 128:376–83.
9. Galione J, Zimmerman M. A comparison of depressed patients with and without borderline personality disorder: implications for interpreting studies of the validity of the bipolar spectrum. J Pers Disord. 2010;24(6):763–72.
10. Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biom Bull. 1946;2:47–53.
11. Cicchetti D, Toth SL. The past achievements and future promises of developmental psychopathology: the coming of age of a discipline. J Child Psychol Psychiatry. 2009;50(1–2): 16–25.
12. APA. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.
13. Chanen AM, McCutcheon LK. Personality disorder in adolescence: the diagnosis that dare not speak its name. Pers Ment Health. 2008;2(1):35–41.
14. National Collaborating Centre for Mental Health. Borderline personality disorder: treatment and management. London: National Institute for Health and Clinical Excellence; 2009. CG78 Contract No.: 78.
15. National Health and Medical Research Council. Clinical practice guideline for the management of borderline personality disorder. Melbourne: National Health and Medical Research Council; 2012.
16. Tackett JL, Balsis S, Oltmanns TF, Krueger RF. A unifying perspective on personality pathology across the life span: developmental considerations for the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders. Dev Psychopathol. 2009;21(3):687–713.
17. Chanen AM, Jovev M, McCutcheon L, Jackson HJ, McGorry PD. Borderline personality disorder in young people and the prospects for prevention and early intervention. Curr Psychiatry Rev. 2008;4(1):48–57.
18. Miller AL, Muehlenkamp JJ, Jacobson CM. Fact or fiction: diagnosing borderline personality disorder in adolescents. Clin Psychol Rev. 2008;28(6):969–81.
19. Chanen AM, Jovev M, Jackson HJ. Adaptive functioning and psychiatric symptoms in adolescents with borderline personality disorder. J Clin Psychiatry. 2007;68(2):297–306.
20. Chanen AM, Jovev M, Djaja D, McDougall E, Yuen HP, Rawlings D, et al. Screening for borderline personality disorder in outpatient youth. J Pers Disord. 2008;22(4):353–64.
21. Ullrich S, Coid J. The age distribution of self-reported personality disorder traits in a household population. J Pers Disord. 2009;23(2):187–200.
22. Johnson JG, Cohen P, Kasen S, Skodol AE, Hamagami F, Brook JS. Age-related change in personality disorder trait levels between early adolescence and adulthood: a communitybased longitudinal investigation. Acta Psychiatr Scand. 2000;102(4):265–75.
23. Samuels J, Eaton WW, Bienvenu O, Brown C, Costa PT, Nestadt G. Prevalence and correlates of personality disorders in a community sample. Br J Psychiatry. 2002;180(6):536–42.
24. Bernstein DP, Cohen P, Velez CN, Schwab-Stone M, Siever LJ, Shinsato L. Prevalence and stability of the DSM-III-R personality disorders in a community-based survey of adolescents. Am J Psychiatry. 1993;150(8):1237–43.
25. Moran P, Coffey C, Mann A, Carlin JB, Patton GC. Personality and substance use disorders in young adults. Br J Psychiatry. 2006;188(4):374–9.
26. Chanen AM, Jackson HJ, McGorry PD, Allott KA, Clarkson V, Yuen HP. Two-year stability of personality disorder in older adolescent outpatients. J Pers Disord. 2004;18(6):526–41.
27. Kaess M, von Ceumern-Lindenstjerna I-A, Parzer P, Chanen AM, Mundt C, Resch F, et al. Axis I and II comorbidity and psychosocial functioning in female adolescents with borderline personality disorder. Psychopathology. 2012;46(1):52–62.
28. Crawford TN, Cohen P, First MB, Skodol AE, Johnson JG, Kasen S. Comorbid Axis I and Axis II disorders in early adolescence: prognosis 20 years later. Arch Gen Psychiatry. 2008;65(6):641–8.
29. Winograd G, Cohen P, Chen H. Adolescent borderline symptoms in the community: prognosis for functioning over 20 years. J Child Psychol Psychiatry. 2008;49(9):933–41.
30. Stepp SD, Pilkonis PA, Hipwell AE, Loeber R, Stouthamer-Loeber M. Stability of borderline personality disorder features in girls. J Pers Disord. 2010;24(4):460–72.
31. Crick NR, Murray-Close D, Woods K. Borderline personality features in childhood: a shortterm longitudinal study. Dev Psychopathol. 2005;17(4):1051–70.
32. Cohen P. Childhood risks for young adult symptoms of personality disorder: method and substance. Multivariate Behav Res. 1996;31(1):121–48.
33. Bernstein DP, Cohen P, Skodol A, Bezirganian S, Brook J. Childhood antecedents of adolescent personality disorders. Am J Psychiatry. 1996;153(7):907–13.
34. Kasen S, Cohen P, Skodol AE, Johnson JG, Brook JS. Infl uence of child and adolescent psychiatric disorders on young adult personality disorder. Am J Psychiatry. 1999;156(10): 1529–35.
35. Crawford TN, Cohen P, Johnson JG, Kasen S, First MB, Gordon K, et al. Self-reported personality disorder in the Children in the Community Sample: convergent and prospective validity in late adolescence and adulthood. J Pers Disord. 2005;19(1):30–52.
36. Chanen AM, Kaess M. Developmental pathways toward borderline personality disorder. Curr Psychiatry Rep. 2012;14(1):45–53.
37. Kraemer HC, Kazdin AE, Offord DR, Kessler RC, Jensen PS, Kupfer DJ. Coming to terms with the terms of risk. Arch Gen Psychiatry. 1997;54(4):337–43.
38. Eaton WW, Badawi M, Melton B. Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset. Am J Psychiatry. 1995;152(7):967–72.
39. Crawford TN, Cohen PR, Chen H, Anglin DM, Ehrensaft M. Early maternal separation and the trajectory of borderline personality disorder symptoms. Dev Psychopathol. 2009;21(3): 1013–30.
40. Carlson EA, Egeland B, Sroufe LA. A prospective investigation of the development of borderline personality symptoms. Dev Psychopathol. 2009;21(4):1311–34.
41. Rohde P, Lewinsohn PM, Kahler CW, Seeley JR, Brown RA. Natural course of alcohol use disorders from adolescence to young adulthood. J Am Acad Child Adolesc Psychiatry. 2001;40(1):83–90.
42. Thatcher DL, Cornelius JR, Clark DB. Adolescent alcohol use disorders predict adult borderline personality. Addict Behav. 2005;30(9):1709–24.
43. Stepp SD, Burke JD, Hipwell AE, Loeber R. Trajectories of attention deficit hyperactivity disorder and oppositional defiant disorder symptoms as precursors of borderline personality disorder symptoms in adolescent girls. J Abnorm Child Psychol. 2012;40:7–20.
44. Burke JD, Stepp SD. Adolescent disruptive behavior and borderline personality disorder symptoms in young adult men. J Abnorm Child Psychol. 2012;40(1):35–44.
45. Leichsenring F, Leibing E, Kruse J, New AS, Leweke F. Borderline personality disorder. Lancet. 2011;377(9759):74–84.
46. Zanarini MC, Frankenburg FR, RidolfiME, Jager-Hyman S, Hennen J, Gunderson JG. Reported childhood onset of self-mutilation among borderline patients. J Pers Disord. 2006;20(1):9–15.
47. Nock MK. Self-injury. Annu Rev Clin Psychol. 2010;6:339–63.
48. Brunner R, Parzer P, Haffner J, Steen R, Roos J, Klett M, et al. Prevalence and psychological correlates of occasional and repetitive deliberate self-harm in adolescents. Arch Pediatr Adolesc Med. 2007;161(7):641–9.
49. Nock MK, Joiner JTE, Gordon KH, Lloyd-Richardson E, Prinstein MJ. Non-suicidal selfinjury among adolescents: diagnostic correlates and relation to suicide attempts. Psychiatry Res. 2006;144(1):65–72.
50. Muehlenkamp JJ, Ertelt TW, Miller AL, Claes L. Borderline personality symptoms differentiate non-suicidal and suicidal self-injury in ethnically diverse adolescent outpatients. J Child Psychol Psychiatry. 2011;52(2):148–55.
51. Jacobson CM, Muehlenkamp JJ, Miller AL, Turner JB. Psychiatric impairment among adolescents engaging in different types of deliberate self-harm. J Clin Child Adolesc Psychol. 2008;37(2):363–75.
52. Cohen P, Chen H, Kasen S, Johnson JG, Crawford T, Gordon K. Adolescent Cluster A personality disorder symptoms, role assumption in the transition to adulthood, and resolution or persistence of symptoms. Dev Psychopathol. 2005;17(2):549–68.
53. Berk M, Berk L, Dodd S, Cotton S, Macneil C, Daglas R, et al. Stage managing bipolar disorder. Bipolar Disord. 2013. DOI: 10.1111/bdi.12099.
54. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord. 1994;31(4):281–94.
55. Berk M, Hallam KT, McGorry PD. The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord. 2007;100(1–3):279–81.
56. Bechdolf A, Ratheesh A, Wood SJ, Tecic T, Conus P, Nelson B, et al. Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder. Curr Pharm Des. 2012;18(4):358–75.
57. Lapalme M, Hodgins S, LaRoche C. Children of parents with bipolar disorder: a metaanalysis of risk for mental disorders. Can J Psychiatry. 1997;42(6):623–31.
58. Oquendo MA, Ellis SP, Chesin MS, Birmaher B, Zelazny J, Tin A, et al. Familial transmission of parental mood disorders: unipolar and bipolar disorders in offspring. Bipolar Disord. 2013;15:764–73.
59. Ryden E, Thase ME, Straht D, Aberg-Wistedt A, Bejerot S, Landen M. A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD. Acta Psychiatr Scand. 2009;120(3):239–46.
60. Faraone SV, Biederman J, Mennin D, Wozniak J, Spencer T. Attention-deficit hyperactivity disorder with bipolar disorder: a familial subtype? J Am Acad Child Adolesc Psychiatry. 1997;36(10):1378–87; discussion 87–90.
61. Marchand WR, Wirth L, Simon C. Adverse life events and pediatric bipolar disorder in a community mental health setting. Community Ment Health J. 2005;41(1):67–75.
62. Garno JL, Goldberg JF, Ramirez PM, Ritzler BA. Impact of childhood abuse on the clinical course of bipolar disorder. Br J Psychiatry. 2005;186:121–5.
63. Strakowski SM, DelBello MP. The co-occurrence of bipolar and substance use disorders. Clin Psychol Rev. 2000;20(2):191–206.
64. Young LT, Bagby RM, Cooke RG, Parker JD, Levitt AJ, Joffe RT. A comparison of Tridimensional Personality Questionnaire dimensions in bipolar disorder and unipolar depression. Psychiatry Res. 1995;58(2):139–43.
65. Thompson KN, Conus PO, Ward JL, Phillips LJ, Koutsogiannis J, Leicester S, et al. The initial prodrome to bipolar affective disorder: prospective case studies. J Affect Disord. 2003;77(1):79–85.
66. Conus P, Ward J, Hallam KT, Lucas N, Macneil C, McGorry PD, et al. The proximal prodrome to first episode mania. Bipolar Disord. 2008;10(5):555–65.
67. Tijssen MJ, van Os J, Wittchen HU, Lieb R, Beesdo K, Mengelers R, et al. Prediction of transition from common adolescent bipolar experiences to bipolar disorder: 10-year study. Br J Psychiatry. 2010;196(2):102–8.
68. Birmaher B, Axelson D, Goldstein B, Strober M, Gill MK, Hunt J, et al. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry. 2009;166(7):795–804.
69. Leibenluft E. Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths. Am J Psychiatry. 2011;168(2):129–42.
70. Bell RQ. Multiple-risk cohorts and segmenting risk as solutions to the problem of false positives in risk for the major psychoses. Psychiatry. 1992;55(4):370–81.
71. Allen NB, Hetrick S, Simmons JG, Hickie IB. Early intervention for depressive disorders in young people: the opportunity and the (lack of) evidence. Med J Aust. 2007;187(7):S15–7.
72. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62(6):617–27.
73. Costello EJ, Pine DS, Hammen C, March JS, Plotsky PM, Weissman MM, et al. Development and natural history of mood disorders. Biol Psychiatry. 2002;52(6):529–42.
74. Gladstone TR, Beardslee WR, O’Connor EE. The prevention of adolescent depression. Psychiatr Clin North Am. 2011;34(1):35–52.
75. Hill J, Pickles A, Rollinson L, Davies R, Byatt M. Juvenile- versus adult-onset depression: multiple differences imply different pathways. Psychol Med. 2004;34(8):1483–93.
76. Fernando K, Carter JD, Frampton CM, Luty SE, McKenzie J, Mulder RT, et al. Childhood-, teenage-, and adult-onset depression: diagnostic and individual characteristics in a clinical sample. Compr Psychiatry. 2011;52(6):623–9.
77. Vandeleur C, Rothen S, Gholam-Rezaee M, Castelao E, Vidal S, Favre S, et al. Mental disorders in offspring of parents with bipolar and major depressive disorders. Bipolar Disord. 2012;14(6):641–53.
78. Hankin BL. Future directions in vulnerability to depression among youth: integrating risk factors and processes across multiple levels of analysis. J Clin Child Adolesc Psychol. 2012;41(5):695–718.
79. Johnson JG, Cohen P, Kasen S, Brook JS. Personality disorder traits associated with risk for unipolar depression during middle adulthood. Psychiatry Res. 2005;136(2–3):113–21.
80. Dolan-Sewell RT, Krueger RF, Shea M. Co-occurrence with syndrome disorders. In: Livesley WJ, editor. Handbook of personality disorders: theory, research, and treatment. New York: Guilford Press; 2001. p. 84–104.
81. Barrachina J, Pascual JC, Ferrer M, Soler J, Rufat MJ, Andion O, et al. Axis II comorbidity in borderline personality disorder is infl uenced by sex, age, and clinical severity. Compr Psychiatry. 2011;52(6):725–30.
82. Eaton NR, Krueger RF, Keyes KM, Skodol AE, Markon KE, Grant BF, et al. Borderline personality disorder co-morbidity: relationship to the internalizing-externalizing structure of common mental disorders. Psychol Med. 2011;41(5):1041–50.
83. Lenzenweger MF, Lane MC, Loranger AW, Kessler RC. DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007;62(6):553–64.
84. Krueger RF, Markon KE. Reinterpreting comorbidity: a model-based approach to understanding and classifying psychopathology. Annu Rev Clin Psychol. 2006;2:111–33.
85. Paris J, Gunderson J, Weinberg I. The interface between borderline personality disorder and bipolar spectrum disorders. Compr Psychiatry. 2007;48(2):145–54.
86. Benazzi F. A relationship between bipolar II disorder and borderline personality disorder? Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(4):1022–9.
87. Barroilhet S, Vöhringer PA, Ghaemi SN. Borderline versus bipolar: differences matter. Acta Psychiatr Scand. 2013;128(5):385–6.
88. Renaud S, Corbalan F, Beaulieu S. Differential diagnosis of bipolar affective disorder type II and borderline personality disorder: analysis of the affective dimension. Compr Psychiatry. 2012;53(7):952–61.
89. Bassett D. Borderline personality disorder and bipolar affective disorder. Spectra or spectre? A review. Aust N Z J Psychiatry. 2012;46(4):327–39.
90. Smith DJ, Muir WJ, Blackwood DHR. Borderline personality disorder characteristics in young adults with recurrent mood disorders: a comparison of bipolar and unipolar depression. J Affect Disord. 2005;87(1):17–23.
91. Moor S, Crowe M, Luty SE, Carter JD, Joyce PR. Effects of comorbidity and early age of onset in young people with bipolar disorder on self harming behaviour and suicide attempts. J Affect Disord. 2012;136:1212–5.
92. Baethge C, Baldessarini RJ, Khalsa HM, Hennen J, Salvatore P, Tohen M. Substance abuse in first-episode bipolar I disorder: indications for early intervention. Am J Psychiatry. 2005; 162(5):1008–10.
93. Berk M, Dodd S, Callaly P, Berk L, Fitzgerald P, de Castella AR, et al. History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder. J Affect Disord. 2007;103(1–3): 181–6.
94. Luca M, Luca A, Calandra C. Borderline personality disorder and depression: an update. Psychiatry Q. 2012;83(3):281–92.
95. Zimmerman ME, Morgan TA. The relationship between borderline personality disorder and bipolar disorder. Dialogues Clin Neurosci. 2013;15(2):155–69.
96. Matza LS, Rajagopalan KS, Thompson CL, de Lissovoy G. Misdiagnosed patients with bipolar disorder: comorbidities, treatment patterns, and direct treatment costs. J Clin Psychiatry. 2005;66(11):1432–40.
97. Zimmerman ME, Galione JN, Ruggero CJ, Chelminski I, Young D, Dalrymple K, et al. Screening for bipolar disorder and finding borderline personality disorder. J Clin Psychiatry. 2010;71(9):1212–7.
98. Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 2009;302(16):1765–73.
99. McGorry PD, van Os J. Redeeming diagnosis in psychiatry: timing versus specificity. Lancet. 2013;381(9863):343–5.
100. McGorry PD. Risk syndromes, clinical staging and DSM V: new diagnostic infrastructure for early intervention in psychiatry. Schizophr Res. 2010;120(1–3):49–53.
101. Cicchetti D, Rogosch FA. A developmental psychopathology perspective on adolescence. J Consult Clin Psychol. 2002;70(1):6–20.
102. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry. 2006;40(8):616–22.
103. Chanen AM, McCutcheon L, Germano D, Nistico H, Jackson HJ, McGorry PD. The HYPE Clinic: an early intervention service for borderline personality disorder. J Psychiatr Pract. 2009;15(3):163–72.
104. Macneil CA, Hallam K, Conus P, Henry L, Kader L, Berk M. Are we missing opportunities for early intervention in bipolar disorder? Expert Rev Neurother. 2012;12(1):5–7.
105. Garber J, Clarke GN, Weersing VR, Beardslee WR, Brent DA, Gladstone TR, et al. Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA. 2009;301(21): 2215–24.
106. Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, et al. N-acetyl cysteine for depressive symptoms in bipolar disorder—a double-blind randomized placebo-controlled trial. Biol Psychiatry. 2008;64(6):468–75.
107. Amminger GP, Chanen AM, Ohmann S, Klier C, Mossaheb N, Bechdolf A, et al. O-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post-hoc subgroup analysis of a double-blind randomised controlled trial. Can J Psychiatry. 2013;58(7):402–8.
108. Zanarini MC, Frankenburg FR. Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry. 2003; 160(1):167–9.
109. Sarris J, Mischoulon D, Schweitzer I. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J Clin Psychiatry. 2012;73(1):81–6.